Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Research

Thermal stability and inactivation of hepatitis C virus grown in cell culture

Authors: Hongshuo Song, Jin Li, Shuang Shi, Ling Yan, Hui Zhuang, Kui Li

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Background

Hepatitis C virus (HCV) is a blood-borne flavivirus that infects many millions of people worldwide. Relatively little is known, however, concerning the stability of HCV and reliable procedures for inactivating this virus.

Methods

In the current study, the thermostability of cell culture-derived HCV (HCVcc, JFH-1 strain) under different environmental temperatures (37°C, room temperature, and 4°C) and the ability of heat, UVC light irradiation, and aldehyde and detergent treatments to inactivate HCVcc were evaluated. The infectious titers of treated viral samples were determined by focus-forming unit (FFU) assay using an indirect immunofluorescence assay for HCV NS3 in hepatoma Huh7-25-CD81 cells highly permissive for HCVcc infection. MTT cytotoxicity assay was performed to determine the concentrations of aldehydes or detergents at which they were no longer cytotoxic.

Results

HCVcc in culture medium was found to survive 37°C and room temperature (RT, 25 ± 2°C) for 2 and 16 days, respectively, while the virus was relatively stable at 4°C without drastic loss of infectivity for at least 6 weeks. HCVcc in culture medium was sensitive to heat and could be inactivated in 8 and 4 min when incubated at 60°C and 65°C, respectively. However, at 56°C, 40 min were required to eliminate HCVcc infectivity. Addition of normal human serum to HCVcc did not significantly alter viral stability at RT or its susceptibility to heat. UVC light irradiation (wavelength = 253.7 nm) with an intensity of 450 μW/cm2 efficiently inactivated HCVcc within 2 min. Exposures to formaldehyde, glutaraldehyde, ionic or nonionic detergents all destroyed HCVcc infectivity effectively, regardless of whether the treatments were conducted in the presence of cell culture medium or human serum.

Conclusions

The results provide quantitative evidence for the potential use of a variety of approaches for inactivating HCV. The ability of HCVcc to survive ambient temperatures warrants precautions in handling and disposing of objects and materials that may have been contaminated with HCV.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lemon SM, Walker C, Alter MJ, Yi M, Knipe D, Howley P, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE: Hepatitis C viruses. In Fields Virology. Fifth edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott Williams & Wilkins; 2007:1253-1304. Lemon SM, Walker C, Alter MJ, Yi M, Knipe D, Howley P, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE: Hepatitis C viruses. In Fields Virology. Fifth edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott Williams & Wilkins; 2007:1253-1304.
2.
go back to reference Webster DP, Klenerman P, Collier J, Jeffery KJ: Development of novel treatments for hepatitis C. Lancet Infect Dis 2009, 9: 108-117. 10.1016/S1473-3099(09)70020-9PubMedCrossRef Webster DP, Klenerman P, Collier J, Jeffery KJ: Development of novel treatments for hepatitis C. Lancet Infect Dis 2009, 9: 108-117. 10.1016/S1473-3099(09)70020-9PubMedCrossRef
3.
go back to reference Alter MJ: The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis 1993, 2: 155-166.PubMed Alter MJ: The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis 1993, 2: 155-166.PubMed
4.
go back to reference Kamili S, Krawczynski K, McCaustland K, Li X, Alter MJ: Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol 2007, 28: 519-524. 10.1086/513727PubMedCrossRef Kamili S, Krawczynski K, McCaustland K, Li X, Alter MJ: Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol 2007, 28: 519-524. 10.1086/513727PubMedCrossRef
5.
go back to reference Hilfenhaus J, Groner A, Nowak T, Weimer T: Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses. Transfusion 1997, 37: 935-940. 10.1046/j.1537-2995.1997.37997454021.xPubMedCrossRef Hilfenhaus J, Groner A, Nowak T, Weimer T: Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses. Transfusion 1997, 37: 935-940. 10.1046/j.1537-2995.1997.37997454021.xPubMedCrossRef
6.
go back to reference Sattar SA, Tetro J, Springthorpe VS, Giulivi A: Preventing the spread of hepatitis B and C viruses: where are germicides relevant? Am J Infect Control 2001, 29: 187-197. 10.1067/mic.2001.114233PubMedCrossRef Sattar SA, Tetro J, Springthorpe VS, Giulivi A: Preventing the spread of hepatitis B and C viruses: where are germicides relevant? Am J Infect Control 2001, 29: 187-197. 10.1067/mic.2001.114233PubMedCrossRef
7.
go back to reference Azar Daryany MK, Hosseini SM, Raie M, Fakharie J, Zareh A: Study on continuous (254 nm) and pulsed UV (266 and 355 nm) lights on BVD virus inactivation and its effects on biological properties of fetal bovine serum. J Photochem Photobiol B 2009, 94: 120-124. 10.1016/j.jphotobiol.2008.10.009PubMedCrossRef Azar Daryany MK, Hosseini SM, Raie M, Fakharie J, Zareh A: Study on continuous (254 nm) and pulsed UV (266 and 355 nm) lights on BVD virus inactivation and its effects on biological properties of fetal bovine serum. J Photochem Photobiol B 2009, 94: 120-124. 10.1016/j.jphotobiol.2008.10.009PubMedCrossRef
8.
go back to reference Remington KM, Trejo SR, Buczynski G, Li H, Osheroff WP, Brown JP, Renfrow H, Reynolds R, Pifat DY: Inactivation of West Nile virus, vaccinia virus and viral surrogates for relevant and emergent viral pathogens in plasma-derived products. Vox Sang 2004, 87: 10-18. 10.1111/j.1423-0410.2004.00530.xPubMedCrossRef Remington KM, Trejo SR, Buczynski G, Li H, Osheroff WP, Brown JP, Renfrow H, Reynolds R, Pifat DY: Inactivation of West Nile virus, vaccinia virus and viral surrogates for relevant and emergent viral pathogens in plasma-derived products. Vox Sang 2004, 87: 10-18. 10.1111/j.1423-0410.2004.00530.xPubMedCrossRef
9.
go back to reference Cai Z, Zhang C, Chang KS, Jiang J, Ahn BC, Wakita T, Liang TJ, Luo G: Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J Virol 2005, 79: 13963-13973. 10.1128/JVI.79.22.13963-13973.2005PubMedPubMedCentralCrossRef Cai Z, Zhang C, Chang KS, Jiang J, Ahn BC, Wakita T, Liang TJ, Luo G: Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J Virol 2005, 79: 13963-13973. 10.1128/JVI.79.22.13963-13973.2005PubMedPubMedCentralCrossRef
10.
go back to reference Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM: Complete replication of hepatitis C virus in cell culture. Science 2005, 309: 623-626. 10.1126/science.1114016PubMedCrossRef Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, Rice CM: Complete replication of hepatitis C virus in cell culture. Science 2005, 309: 623-626. 10.1126/science.1114016PubMedCrossRef
11.
go back to reference Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005, 11: 791-796. 10.1038/nm1268PubMedPubMedCentralCrossRef Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005, 11: 791-796. 10.1038/nm1268PubMedPubMedCentralCrossRef
12.
go back to reference Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV: Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005, 102: 9294-9299. 10.1073/pnas.0503596102PubMedPubMedCentralCrossRef Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV: Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005, 102: 9294-9299. 10.1073/pnas.0503596102PubMedPubMedCentralCrossRef
13.
go back to reference Akazawa D, Date T, Morikawa K, Murayama A, Miyamoto M, Kaga M, Barth H, Baumert TF, Dubuisson J, Wakita T: CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol 2007, 81: 5036-5045. 10.1128/JVI.01573-06PubMedPubMedCentralCrossRef Akazawa D, Date T, Morikawa K, Murayama A, Miyamoto M, Kaga M, Barth H, Baumert TF, Dubuisson J, Wakita T: CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol 2007, 81: 5036-5045. 10.1128/JVI.01573-06PubMedPubMedCentralCrossRef
14.
go back to reference Burnouf T, Radosevich M: Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev 2000, 14: 94-110. 10.1054/blre.2000.0129PubMedCrossRef Burnouf T, Radosevich M: Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev 2000, 14: 94-110. 10.1054/blre.2000.0129PubMedCrossRef
15.
go back to reference Schlegel A, Immelmann A, Kempf C: Virus inactivation of plasma-derived proteins by pasteurization in the presence of guanidine hydrochloride. Transfusion 2001, 41: 382-389. 10.1046/j.1537-2995.2001.41030382.xPubMedCrossRef Schlegel A, Immelmann A, Kempf C: Virus inactivation of plasma-derived proteins by pasteurization in the presence of guanidine hydrochloride. Transfusion 2001, 41: 382-389. 10.1046/j.1537-2995.2001.41030382.xPubMedCrossRef
16.
go back to reference Charm SE, Landau S, Williams B, Horowitz B, Prince AM, Pascual D: High-temperature short-time heat inactivation of HIV and other viruses in human blood plasma. Vox Sang 1992, 62: 12-20. 10.1111/j.1423-0410.1992.tb01160.xPubMedCrossRef Charm SE, Landau S, Williams B, Horowitz B, Prince AM, Pascual D: High-temperature short-time heat inactivation of HIV and other viruses in human blood plasma. Vox Sang 1992, 62: 12-20. 10.1111/j.1423-0410.1992.tb01160.xPubMedCrossRef
17.
go back to reference Darnell ME, Subbarao K, Feinstone SM, Taylor DR: Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods 2004, 121: 85-91. 10.1016/j.jviromet.2004.06.006PubMedCrossRef Darnell ME, Subbarao K, Feinstone SM, Taylor DR: Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods 2004, 121: 85-91. 10.1016/j.jviromet.2004.06.006PubMedCrossRef
18.
go back to reference Perdiz D, Grof P, Mezzina M, Nikaido O, Moustacchi E, Sage E: Distribution and repair of bipyrimidine photoproducts in solar UV-irradiated mammalian cells. Possible role of Dewar photoproducts in solar mutagenesis. J Biol Chem 2000, 275: 26732-26742.PubMed Perdiz D, Grof P, Mezzina M, Nikaido O, Moustacchi E, Sage E: Distribution and repair of bipyrimidine photoproducts in solar UV-irradiated mammalian cells. Possible role of Dewar photoproducts in solar mutagenesis. J Biol Chem 2000, 275: 26732-26742.PubMed
19.
go back to reference Fraenkel-Conrat H: Reaction of nucleic acid with formaldehyde. Biochim Biophys Acta 1954, 15: 307-309. 10.1016/0006-3002(54)90083-9PubMedCrossRef Fraenkel-Conrat H: Reaction of nucleic acid with formaldehyde. Biochim Biophys Acta 1954, 15: 307-309. 10.1016/0006-3002(54)90083-9PubMedCrossRef
20.
go back to reference Jiang W, Schwendeman SP: Formaldehyde-mediated aggregation of protein antigens: comparison of untreated and formalinized model antigens. Biotechnol Bioeng 2000, 70: 507-517. 10.1002/1097-0290(20001205)70:5<507::AID-BIT5>3.0.CO;2-CPubMedCrossRef Jiang W, Schwendeman SP: Formaldehyde-mediated aggregation of protein antigens: comparison of untreated and formalinized model antigens. Biotechnol Bioeng 2000, 70: 507-517. 10.1002/1097-0290(20001205)70:5<507::AID-BIT5>3.0.CO;2-CPubMedCrossRef
21.
go back to reference Payan C, Cottin J, Lemarie C, Ramont C: Inactivation of hepatitis B virus in plasma by hospital in-use chemical disinfectants assessed by a modified HepG2 cell culture. J Hosp Infect 2001, 47: 282-287. 10.1053/jhin.2001.0945PubMedCrossRef Payan C, Cottin J, Lemarie C, Ramont C: Inactivation of hepatitis B virus in plasma by hospital in-use chemical disinfectants assessed by a modified HepG2 cell culture. J Hosp Infect 2001, 47: 282-287. 10.1053/jhin.2001.0945PubMedCrossRef
22.
go back to reference Roberts PL, Dunkerley C: Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor IX concentrate. Vox Sang 2003, 84: 170-175. 10.1046/j.1423-0410.2003.00275.xPubMedCrossRef Roberts PL, Dunkerley C: Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor IX concentrate. Vox Sang 2003, 84: 170-175. 10.1046/j.1423-0410.2003.00275.xPubMedCrossRef
23.
go back to reference Kim IS, Choi YW, Woo HS, Chang CE, Lee S: Solvent/detergent inactivation and chromatographic removal of human immunodeficiency virus during the manufacturing of a high purity antihemophilic factor VIII concentrate. J Microbiol 2000, 38: 187-191. Kim IS, Choi YW, Woo HS, Chang CE, Lee S: Solvent/detergent inactivation and chromatographic removal of human immunodeficiency virus during the manufacturing of a high purity antihemophilic factor VIII concentrate. J Microbiol 2000, 38: 187-191.
24.
go back to reference Yi M, Ma Y, Yates J, Lemon SM: Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 2007, 81: 629-638. 10.1128/JVI.01890-06PubMedPubMedCentralCrossRef Yi M, Ma Y, Yates J, Lemon SM: Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 2007, 81: 629-638. 10.1128/JVI.01890-06PubMedPubMedCentralCrossRef
Metadata
Title
Thermal stability and inactivation of hepatitis C virus grown in cell culture
Authors
Hongshuo Song
Jin Li
Shuang Shi
Ling Yan
Hui Zhuang
Kui Li
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-40

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue